Global Nerve Repair & Regeneration Market
- Report Code: HE 1021
- Publish Date: Upcoming
The global nerve repair & regeneration market is mainly driven by the rapidly aging population, growing number of peripheral nerve injuries, and associated diseases like Alzheimer’s, epilepsy, and Parkinson’s.
The nerve repair & regeneration market value was $4680.82 million in 2013 and is expected to be $8,112.19 million by 2018, at a CAGR of 11.6%. The neuromodulation market is the largest segment of $4.5 billion of overall nerve repair & regeneration market.
The report “Nerve Repair & Regeneration Market Forecast, 2012-2018”, analyzes the peripheral nerve repair market that includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation market includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The segmentation of the market would experience a positive growth till 2018 with an increased awareness for procedures and sophisticated diagnostic techniques. With a market value of $4.6billion and $4.5 billion, peripheral nerve repair and neuromodulation segments have been contributing towards total nerve repair & regeneration market. Both the markets have been witnessing the maximum growth because of increase in patient pool and procedure numbers of direct nerve repair, nerve grafting, and stem cell therapy and neurostimulation/neuromodulation surgery.
Procedure volume growth is higher in North America, Europe, India, and China because of fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people.
Both the segments experienced a slow growth in 2012 in Japan due to reimbursement protocols instituted by the Japanese government, which limited ASP growth.
North America accounted the largest share of around 60% of the global nerve repair & regeneration market till 2013. RoW is projected to grow at the highest CAGR of 16.80% from 2013 to 2018. Rising awareness and growing demand of nerve repair products, and increased investments in regions such as the Middle East and Latin America are driving the growth of this market. The high prevalence is due to the rise in aging population (with multiple disorders such as Alzheimer’s, Parkinson’s, chronic pain, and epilepsy), increasing incidence of peripheral nerve injuries, favorable reimbursement policies, and technological advancements
The report provides an extensive competitive landscaping of companies operating in this market. The main companies operating in peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). The details of segment and country-specific company shares, news and deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies is also covered in the report
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of peripheral nerve injuries
- Country-specific patient pool of Alzheimer’s and Parkinson’s disease, acute chronic pain, and epilepsy
- Disease progression (pattern analysis)
Procedure Volume Data
- Number of direct nerve repair, nerve grafting, stem cell therapy and neurostimulation/neuromodulation procedures performed in each country
Surgeons/Physicians Perception analysis
- Fast turn-around analysis of surgeons response to market events and trends
- Pattern analysis of usage of Nerve grafting through xenografts or biomaterials and neuromodulation by physicians
- Surgeon’s opinion about products from different companies
- Surgeon’s qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of nerve repair and regeneration devices in major countries
- direct nerve repair, nerve grafting, and stem cell therapy procedural investment in major countries
Competitive Intelligence
- The company share analysis of nerve repair & regeneration market top players in the region
- The crucial developments and strategies of companies inculcating in their portfolio
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Global Neurostimulation/Neuromodulation Market Global Neurostimulation/Neuromodulation market is expected to reach from $4503.9 million in 2013 to $7810.4 million by 2018 at a CAGR of 11.6%. The Neuromodulation market is the largest segment 96% of Nerve Repair & regeneration market. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Upcoming |
|
|
North American Nerve Repair & Regeneration Market The North American Nerve Repair and Regeneration market was pegged at $2841.03 million in 2013 and expected to be $4709.59 million by 2018, growing at a CAGR of 10.6%. Nerve Repair and Regeneration market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating The North American Nerve Repair and Regeneration market segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Apr 2015 |
|
|
European Nerve Repair & Regeneration Market The nerve repair and regeneration market in Europe has displayed significant growth at a CAGR of 11.9%. Germany garnered the maximum market share and is expected to grow at a CAGR of 11.1%, followed by France and the U.K. |
Apr 2015 |
|
|
Asian Nerve Repair & Regeneration Market The Asian Nerve Repair and Regeneration market was pegged at $4680.82 million in 2013 and expected to be $8112.19 million by 2018, growing at a CAGR of 11.6%. market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating in peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Mar 2015 |
|
|
Asian Internal Neurostimulation The Asian internal neurostimulation market was $271.80 million in 2013, and expected to reach $546.6 million by 2018 at a CAGR of 15.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Johnson & Johnson and Greenbatch Inc,. |
Mar 2015 |
|
|
Global Internal Neurostimulation Market The Internal Neurostimulation market was $3903.2 million in 2013 and expected to reach $6828.8 million by 2018 at a CAGR of 11.8%. The Internal Neuromodulation market is the largest segment 87% of Overall Neurostimulation/Neuromodulation market. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical. |
Apr 2015 |
|
|
European Internal Neurostimulation The European internal neurostimulation market was $947.8 million in 2013, and is expected to reach $1715.8 million by 2018 at a CAGR of 13.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S), and Neuronetics, Inc (U.S.). Emerging players in this market include Biocontrol Medical, ANM Neuromodulation GmbH and Magstim Company Limited. |
Upcoming |
|
|
North American Internal Neurostimulation The North American Internal Neurostimulation market was $2548.27 million in 2013 and expected to reach $4242.09 million by 2018 at a CAGR of 10.7%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical. |
Upcoming |
|
|
Asian Neurostimulation/Neuromodulation devices Market The Asian Neurostimulation/Neuromodulation market was expected to reach from $415.32 million in 2013 to $777.62 million by 2018 at a CAGR of 13.4%. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Upcoming |
|
|
European Neurostimulation/Neuromodulation Devices Market The report also provides a detailed competitive landscaping of companies operating in this market. Segment- and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of major companies are detailed in the report. Boston Scientific (U.S.), Cyberonics (U.S), Medtronic, Inc. (U.S.), Depuy Synthes (Johnson & Johnson) (U.S.), and St. Jude Medical Inc. (U.S.) are some of the key players engaged in this market. |
May 2015 |
|
|
North America Internal Neuromodulation Devices Market The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a share of 85.9% in the neuromodulation market. |
May 2015 |
|
|
External Neurostimulation The External Neurostimulation market was $600 million in 2013 and expected to reach $983.7 million by 2018 at a CAGR of 10.4%. The External Neurostimulation market segmented by 2 modalities Transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS). Major players in the External Neurostimulation market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). Emerging players include Functional Neuromodulation Ltd. (U.S.), MicroTransponder, Inc. (U.S.), Zynex Medical, Inc. (U.S.) and Neurotech SA – a Sorin Group Company (Belgium). |
Upcoming |
|
|
Spinal cord stimulator Spinal cord stimulator and Deep Brain Stimulator, Sacral... |
Upcoming |
|
|
Deep Brain Stimulator Deep Brain Stimulator and Spinal cord stimulator, |
Upcoming |
|
|
Sacral Nerve Stimulator Sacral Nerve Stimulator and Spinal cord stimulator, Deep... |
Upcoming |
|
|
Vagus Nerve Stimulator Vagus Nerve Stimulator and Spinal cord stimulator, Deep... |
Upcoming |
|
|
Gastric Electrical stimulator Gastric Electrical stimulator and Spinal cord stimulator, |
Upcoming |
|
|
TENS SECTIONS Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation adds up to total |
Upcoming |
|
|
Transcranial Magnetic Stimulation Transcranial Magnetic Stimulation and Transcutaneous Electrical Nerve Stimulation adds up to total |
Upcoming |
|
|
North American External Neurostimulation / Neuromodulation devices Market The North American external neurostimulation/neuromodulation market is expected to grow significantly due to the growing awareness of consumers and the demand of the aging population to treat prevalent lifestyle & chronic disorders such as arthritis, migraines, and so on. The market report provides information and analysis of the market values, drivers & restraints, competitive scenario, and market opportunities, among others. The U.S., Canada, and Mexico are the major countries that have been considered for this extensive market analysis. |
Upcoming |
